Formulations of pimavanserin | Patent Number 10449185

US 10449185 B2
Application Number16363378
Publication NumberUS 20190216791 A1
Pendency7 months, 1 day
Filled DateMar 25, 2019
Priority Date-
Publication DateJul 18, 2019
Expiration DateMar 24, 2039
Inventor/ApplicantsEmanuel Joseph Vizzotti
Ravi Tejwani
Stephen Edward Abele
ExaminesYOUNG, MICAH PAUL
Art Unit1618
Technology Center1600
Assignments
Acadia Pharmaceuticals Inc.
Current
Acadia Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.